Last updated on September 2017

Clinical Evaluation of the Cochlear Nucleus CI532 Cochlear Implant in Adults


Brief description of study

The purpose of this study is to gather long-term data on the FDA approved CI532 cochlear implant, and CP1000 (Nucleus 7) sound processor

Detailed Study Description

Appropriate candidates will receive a CI532 cochlear implant and be fit with the CP1000 sound processor. Imaging will be completed pre-op, intra-op, and post-op to assess implant location. Speech perception testing as well as subjective questionnaires will be administered over 12 months.

Clinical Study Identifier: NCT03007472

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Charles Limb, MD

University of California, San Francisco
San Francisco, CA United States
  Connect »

David Kelsall, MD

Rocky Mountain Ear Center
Englewood, CO United States
  Connect »

Bruce Gantz, MD

University of Iowa
Iowa City, IA United States
  Connect »

Teresa Zwolan, PhD

University of Michigan
Ann Arbor, MI United States
  Connect »

Jacques Herzog, MD

The Center for Hearing and Balance Disorders
Chesterfield, MO United States
  Connect »

Robert Cullen, MD

Midwest Ear Institute
Kansas City, MO United States
  Connect »

Craig Buchman, MD

Washington University
Saint Louis, MO United States
  Connect »

Susan Waltzman, PhD

New York University
New York, NY United States
  Connect »

Oliver Adunka, MD

The Ohio State University
Columbus, OH United States
  Connect »

Mark Wood, MD

Hearts for Hearing
Oklahoma City, OK United States
  Connect »

Robert Peters, MD

Dallas Ear Institute
Dallas, TX United States
  Connect »

Brian Perry, MD

Ear Medical Group
San Antonio, TX United States
  Connect »

Neil Giddings, MD

Spokane ENT
Spokane, WA United States
  Connect »